Clinical Trial Update: A Phase 2b Dose Finding Study of RMC-035 in Participants Undergoing Open-chest Cardiac Surgery [Phase 2]

View source ↗

Summary

Phase 2b dose-finding trial evaluating RMC-035 in adults undergoing open-chest cardiac surgery has completed. The study aimed to identify optimal dosing to prev…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Drugs mentioned

• RMC-035

Snippet

Sponsor: Guard Therapeutics AB | Conditions: Kidney Injury Following Open-Chest Cardiac Surgery | Phase 2 | Status: COMPLETED